Clinical-stage biopharma, Applied Therapeutics, updated the filing for its upcoming IPO. The company will raise up to $86 million. It intends to trade under the symbol, "APLT", on NASDAQ.
... read more
Clinical-stage biopharma, Applied Therapeutics, updated the filing for its upcoming IPO. The company will raise up to $86 million. It intends to trade under the symbol, "APLT", on NASDAQ.
... read more
On 4/22/19, Gritstone Oncology filed for a $102 Million offering of its common stock. Gritstone trades on NASDAQ under the symbol, “GRTS.” The company currently has a market cap of $394 Million.... read more
On 4/22/19, TransMedics updated their filing for an IPO to raise up to $91 million. The commercial stage company has developed an organ transplant support system for heart, lung and liver... read more
Clinical stage biopharmaceutical company, Trevi Therapeutics, updated their filing for an IPO to raise up to $74 million. Trevi is focused on the development and commercialization of nalbuphine ER... read more
